AbstractFirst-line multiple myeloma treatment has evolved from melphalan–prednisone to quadruplet regimens incorporating proteasome inhibitors, immunomodulatory drugs, anti-CD38 monoclonal antibodies, ...
To help defray the rising costs of initial manuscript screening and publication, the AACR journals levy fees as detailed herein. Authors are required to confirm at the time of submission that they ...
Cancer Discov (2026) 16 (3): OF1.
1Department of Gastroenterology, Ajou University School of Medicine, Suwon, Republic of Korea. 2BK21 R&E Initiative for Advanced Precision Medicine, Ajou University School of Medicine, Suwon, Republic ...
1National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Artificial intelligence systems are beginning to function as “co-scientists” in cancer research, generating drug candidates, prioritizing immunotherapy targets, and guiding experimental design.
1Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York. 2Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results